Breast cancer is one of the most common malignant neoplasms among women and ranks first among female cancer diseases.
Early detection of the disease significantly increases treatment effectiveness and can contribute to reducing mortality.
About 2.5 million new cases of breast cancer are registered worldwide every year.
About 70% of women with breast cancer do not have pronounced risk factors, which makes regular screening especially important.
Thanks to mammographic screening, it is possible to detect a malignant tumor on average 3-4 years earlier than a woman can notice it herself.
The breast cancer screening examination included in the universal health insurance package is intended for asymptomatic women aged 45-68 who belong to the at-risk age group. Within the framework of the program, a mammographic examination is carried out using a digital mammography device.
Address
Yerevan, Titogradyan 14Phone Number
+37455929715Address
Fanarjyan 76Phone Number
+37410205050Address
Akhuryan villagePhone Number
+37494821585Breast cancer screening: Short answers to frequently asked questions.
Screening mammography can detect breast cancer at an early stage, even before it becomes palpable. Early detection increases treatment efficacy and improves the survival prognosis.
The target group for breast cancer screening programs consists of asymptomatic women aged 45 to 68.
Screening mammography is performed once every 2 years.
Yes. Screening is specifically intended for asymptomatic women, as cancer often does not cause any complaints or symptoms in its early stages.
Some women may feel brief discomfort or pressure during the test, but it usually lasts for just a few seconds.